Clinical Trial Update: A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study)

View source ↗

Summary

This document describes the REVIVE study, a clinical trial evaluating the safety and effectiveness of venetoclax in patients with acute myeloid leukemia. The tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Venclexta (venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Acute Myeloid Leukemia | Status: ACTIVE_NOT_RECRUITING